Back to Search
Start Over
Gender Differences in Guideline-Directed Medical Therapy for Cardiovascular Disease Among Young Veterans
- Source :
- Journal of general internal medicine, vol 37, iss Suppl 3
- Publication Year :
- 2022
- Publisher :
- eScholarship, University of California, 2022.
-
Abstract
- Background There is an increasing burden of cardiovascular disease, including coronary artery disease (CAD) and heart failure (HF), among women Veterans. Clinical practice guidelines recommend multiple pharmacotherapies that can reduce risk of mortality and adverse cardiovascular outcomes. Objective To determine if there are disparities in the use of guideline-directed medical therapy by gender among Veterans with incident CAD and HF. Design Retrospective. Participants Veterans (934,504; 87.8% men and 129,469; 12.2% women) returning from Operations Enduring Freedom, Iraqi Freedom, and New Dawn. Main Measures Differences by gender in the prescription of Class 1, Level of Evidence A guideline-directed medical therapy among patients who developed incident CAD and HF at 30 days, 90 days, and 12 months after diagnosis. For CAD, medications included statins and antiplatelet therapy. For HF, medications included beta-blockers and renin-angiotensin-aldosterone system inhibitors. Key Results Overall, women developed CAD and HF at a younger average age than men (mean 45.8 vs. 47.7 years, pp Conclusions Despite guideline recommendations, young women Veterans have approximately half the odds of being prescribed guideline-directed medical therapy within 1-year after a diagnosis of HF. These results highlight the need to develop targeted strategies to minimize gender disparities in CVD care to prevent adverse outcomes in this young and growing population.
- Subjects :
- Male
Clinical Sciences
heart failure
Coronary Artery Disease
Cardiovascular
Sex Factors
cardiovascular disease
Clinical Research
General & Internal Medicine
Internal Medicine
Humans
Heart Disease - Coronary Heart Disease
Retrospective Studies
Veterans
Heart Failure
Prevention
Evaluation of treatments and therapeutic interventions
medical therapy
Heart Disease
Good Health and Well Being
Cardiovascular Diseases
gender differences
6.1 Pharmaceuticals
Female
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Platelet Aggregation Inhibitors
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Journal of general internal medicine, vol 37, iss Suppl 3
- Accession number :
- edsair.doi.dedup.....dc0d852656be4f24d7835cb6c33d937a